Hyperfibrinogenemia after preoperative chemoradiotherapy predicts poor response and poor prognosis in rectal cancer

International Journal of Colorectal Disease

Volumn 26, Issue 1, 2011, Pages 45-51

  Kawai, Kazushige ^a   Kitayama, Joji ^a   Tsuno, Nelson H ^a   Sunami, Eiji ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chemoradiotherapy; CRP; Fibrinogen; Rectal cancer

Indexed keywords

C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; FIBRINOGEN; FLUOROURACIL;

ADULT; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; HUMAN; HYPERFIBRINOGENEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIATION RESPONSE; RECTUM CARCINOMA; RECTUM RESECTION; RETROSPECTIVE STUDY; TUMOR REGRESSION; TUMOR VOLUME;

C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; DISEASE-FREE SURVIVAL; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 78751574224     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-1054-y     Document Type: Article

References (37)

1. Y Tomimaru M Yano K Takachi K Kishi I Miyashiro M Ohue, et al. 2006 Plasma D-dimer levels show correlation with number of lymph node metastases in patients with esophageal cancer J Am Coll Surg 202 1 139 145 10.1016/j.jamcollsurg.2005.08.008 16377507 (Pubitemid 43000354)
2. G Altiay A Ciftci M Demir Z Kocak N Sut E Tabakoglu, et al. 2007 High plasma D-dimer level is associated with decreased survival in patients with lung cancer Clin Oncol R Coll Radiol 19 7 494 498 1:STN:280:DC%2BD2svls1GisA%3D%3D 17513096
3. M Kilic O Yoldas M Keskek T Ertan M Tez E Gocmen, et al. 2008 Prognostic value of plasma D-dimer levels in patients with colorectal cancer Colorectal Dis 10 3 238 241 1:STN:280:DC%2BD1c7gtF2itg%3D%3D 10.1111/j.1463-1318.2007.01374.x 17868411 (Pubitemid 351284674)
4. N Levitan A Dowlati SC Remick HI Tahsildar LD Sivinski R Beyth, et al. 1999 Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Med Baltim 78 5 285 291 1:STN:280:DyaK1MvivVymug%3D%3D 10.1097/00005792- 199909000-00001 (Pubitemid 29439263)
5. H Yamashita J Kitayama H Nagawa 2005 Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer Jpn J Clin Oncol 35 10 595 600 10.1093/jjco/hyi150 16186176 (Pubitemid 41662696)
6. H Yamashita J Kitayama N Kanno Y Yatomi H Nagawa 2006 Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer BMC Cancer 6 147 10.1186/1471-2407-6-147 16740157 (Pubitemid 44057311)
7. H Yamashita J Kitayama M Taguri H Nagawa 2009 Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response World J Surg 33 6 1298 1305 10.1007/s00268-009-9992-7 19347392
8. H ten Cate A Falanga 2008 Overview of the postulated mechanisms linking cancer and thrombosis Pathophysiol Haemost Thromb 36 3-4 122 130 19176985
9. R Sauer H Becker W Hohenberger C Rodel C Wittekind R Fietkau, et al. 2004 Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 17 1731 1740 1:CAS:528:DC%2BD2cXovFSksbo%3D 10.1056/NEJMoa040694 15496622 (Pubitemid 39383208)
10. T Watanabe H Nagawa 2004 Sphincter preservation in locally advanced rectal cancer due to the addition of continuous infusion 5-FU to preoperative radiation therapy or advances in surgical techniques? Int J Radiat Oncol Biol Phys 59 2 618 15145184 author reply 618
11. JF Bosset L Collette G Calais L Mineur P Maingon L Radosevic-Jelic, et al. 2006 Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 11 1114 1123 1:CAS:528:DC%2BD28XpsFKkur8%3D 10.1056/NEJMoa060829 16971718 (Pubitemid 44394918)
12. CG Fu O Tominaga H Nagawa ME Nita T Masaki G Ishimaru, et al. 1998 Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients Dis Colon Rectum 41 1 68 74 1:STN:280: DyaK1c7mvFWgsQ%3D%3D 10.1007/BF02236898 9510313 (Pubitemid 28044878)
13. F Marquardt F Rodel G Capalbo C Weiss C Rodel 2009 Molecular targeted treatment and radiation therapy for rectal cancer Strahlenther Onkol 185 6 371 378 10.1007/s00066-009-1936-5 19506820
14. JG Kuremsky JE Tepper HL McLeod 2009 Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 74 3 673 688 1:CAS:528:DC%2BD1MXmsFyiu7g%3D 10.1016/j.ijrobp.2009.03.003 19480968
15. M Kikuchi T Mikami T Sato W Tokuyama K Araki M Watanabe, et al. 2009 High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction Br J Cancer 101 1 116 123 1:CAS:528: DC%2BD1MXotVKguro%3D 10.1038/sj.bjc.6605105 19491899
16. Y Komuro T Watanabe Y Hosoi Y Matsumoto K Nakagawa N Tsuno, et al. 2002 The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma Cancer 95 6 1199 1205 10.1002/cncr.10807 12216085 (Pubitemid 35013052)
17. Y Komuro T Watanabe G Tsurita T Muto H Nagawa 2005 Evaluating the combination of molecular prognostic factors in tumor radiosensitivity in rectal cancer Hepatogastroenterology 52 63 666 671 1:CAS:528:DC%2BD2MXlvFOnur0%3D 15966178
18. Y Komuro T Watanabe G Tsurita T Muto H Nagawa 2005 Expression pattern of telomerase reverse transcriptase in rectal carcinoma predicts tumor radiosensitivity, local recurrence and disease-free survival Hepatogastroenterology 52 64 985 989 1:CAS:528:DC%2BD2MXmsV2kurk%3D 16001613
19. O Dworak L Keilholz A Hoffmann 1997 Pathological features of rectal cancer after preoperative radiochemotherapy Int J Colorectal Dis 12 1 19 23 1:STN:280:DyaK2s3ms1emsw%3D%3D 10.1007/s003840050072 9112145 (Pubitemid 27138353)
20. J Marchena MA Acosta F Garcia-Anguiano H Simpson F Cruz 2003 Use of the preoperative levels of CEA in patients with colorectal cancer Hepatogastroenterology 50 52 1017 1020 1:CAS:528:DC%2BD3sXlsFajtrk%3D 12845969
21. CM Redman H Xia 2001 Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion Ann NY Acad Sci 936 480 495 1:CAS:528:DC%2BD3MXlsV2rt7w%3D 10.1111/j.1749-6632.2001.tb03535.x 11460506
22. WZ Martini 2009 Fibrinogen metabolic responses to trauma Scand J Trauma Resusc Emerg Med 17 1 2 10.1186/1757-7241-17-2 19144127
23. D Collen GN Tytgat H Claeys R Piessens 1972 Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans Br J Haematol 22 6 681 700 1:CAS:528:DyaE38XksF2ls78%3D 10.1111/j.1365-2141.1972. tb05715.x 5064500
24. Z Zhang GM Fuller 2000 Interleukin 1beta inhibits interleukin 6-mediated rat gamma fibrinogen gene expression Blood 96 10 3466 3472 1:CAS:528: DC%2BD3cXotFKkurY%3D 11071643
25. U Albrecht X Yang R Asselta V Keitel ML Tenchini S Ludwig, et al. 2007 Activation of NF-kappaB by IL-1beta blocks IL-6-induced sustained STAT3 activation and STAT3-dependent gene expression of the human gamma-fibrinogen gene Cell Signal 19 9 1866 1878 1:CAS:528:DC%2BD2sXot1Oruro%3D 10.1016/j.cellsig.2007.04.007 17543500 (Pubitemid 47081379)
26. G Grieninger PW Plant TJ Liang RG Kalb D Amrani MW Mosesson, et al. 1983 Hormonal regulation of fibrinogen synthesis in cultured hepatocytes Ann NY Acad Sci 408 469 489 1:CAS:528:DyaL3sXltleksb8%3D 10.1111/j.1749-6632.1983.tb23267.x 6307104
27. V Seebacher S Polterauer C Grimm H Husslein H Leipold K Hefler-Frischmuth, et al. 2010 The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial Br J Cancer 102 6 952 956 1:CAS:528:DC%2BC3cXjt1ymsrw%3D 10.1038/sj.bjc.6605547 20160724
28. BJ Rybarczyk PJ Simpson-Haidaris 2000 Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells Cancer Res 60 7 2033 2039 1:CAS:528:DC%2BD3cXisVymsrk%3D 10766195
29. T Yamaguchi Y Yamamoto S Yokota M Nakagawa M Ito T Ogura 1998 Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients Jpn J Clin Oncol 28 12 740 744 1:STN:280:DyaK1M%2FpsFeltg%3D%3D 10.1093/jjco/28.12.740 9879291
30. J Panes DN Granger 1996 Neutrophils generate oxygen free radicals in rat mesenteric microcirculation after abdominal irradiation Gastroenterology 111 4 981 989 1:CAS:528:DyaK28XmsFCrsr4%3D 10.1016/S0016-5085(96)70065-3 8831592
31. A Debucquoy L Goethals K Geboes S Roels WH McBride K Haustermans 2006 Molecular responses of rectal cancer to preoperative chemoradiation Radiother Oncol 80 2 172 177 1:CAS:528:DC%2BD28Xptlyksrk%3D 10.1016/j.radonc.2006.07.016 16905208 (Pubitemid 44301536)
32. MW Wichmann G Meyer M Adam W Hochtlen-Vollmar MK Angele A Schalhorn, et al. 2003 Detrimental immunologic effects of preoperative chemoradiotherapy in advanced rectal cancer Dis Colon Rectum 46 7 875 887 10.1007/s10350-004-6677-z 12847360 (Pubitemid 36875481)
33. PJ Simpson-Haidaris B Rybarczyk 2001 Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein Ann NY Acad Sci 936 406 425 1:CAS:528:DC%2BD3MXlsV2rtrw%3D 10.1111/j.1749-6632.2001.tb03525.x 11460495
34. JS Palumbo JM Potter LS Kaplan K Talmage DG Jackson JL Degen 2002 Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice Cancer Res 62 23 6966 6972 1:CAS:528:DC%2BD38XpsVahsb4%3D 12460914
35. S Zheng J Shen Y Jiao Y Liu C Zhang M Wei, et al. 2009 Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity Cancer Sci 100 5 859 865 1:CAS:528:DC%2BD1MXls1Srtb0%3D 10.1111/j.1349-7006.2009.01115.x 19302289
36. NJ Brown CA Staton GR Rodgers KP Corke JC Underwood CE Lewis 2002 Fibrinogen E fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model Br J Cancer 86 11 1813 1816 1:CAS:528:DC%2BD38XkvVaitrc%3D 10.1038/sj.bjc.6600320 12087471 (Pubitemid 34712928)
37. N Akakura C Hoogland YK Takada J Saegusa X Ye FT Liu, et al. 2006 The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth Cancer Res 66 19 9691 9697 1:CAS:528:DC%2BD28XhtVams7rM 10.1158/0008-5472.CAN-06-1686 17018627 (Pubitemid 44623669)